This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
BackgroundAtrial fibrillation (AF) is the most prevalent cardiac arrhythmia worldwide, posing significant health burdens. Pulsed field ablation (PFA) is an emerging non-thermal technique that is gaining traction due to the ability to selectively target myocardial cells and minimize damage to surrounding tissues.
Additional relevant studies, published through November 2022, during the guideline writing process, were also considered by the writing committee and added to the evidence tables, where appropriate.StructureAtrial fibrillation is the most sustained common arrhythmia, and its incidence and prevalence are increasing in the United States and globally.
Introduction A high recurrence rate of atrialfibrillation was monitored after catheter ablation for persistent atrialfibrillation. Trial Registration Registered with Chinese Clinical Trials Registry on 27 August 2022, identifier: ChiCTR2200062995.
Backgroundwide antral pulmonary vein isolation (PVI) is effective for treating paroxysmal atrialfibrillation (PAF), although time-demanding. Procedural data and electrophysiology (EP) laboratory times were systematically collected and analyzed.
Better tissue selectivity of primarily non-thermic pulsed field ablation (PFA) may eliminate collateral injury, particularly the risk of atrio-esophageal fistula (AEF). Following PFA-PVI, none of the patients had mucosal lesions, food retention, or ablation-induced vagal nerve injury; four patients showed periesophageal edema.
Procedures that leverage transseptal delivery include atrialfibrillationablation , patent foramen ovale (PFO) and atrial septal defect (ASD) repair, percutaneous mitral valve repair, left atrial appendage closure, and percutaneous left ventricular assist device placement, among others.
Introduction:Catheter ablation (CA) is superior to medical therapy in the management of atrialfibrillation (AF). The median follow-up duration for the patient population was 1168 days post-ablation. Catheter ablation was presumed successful in 19/32 patients who experienced a CVA. Conclusions:CVA occurred in 1.4%
Abstract Introduction In hypertrophic cardiomyopathy (HCM), atrialfibrillation (AF) has historically been regarded to have a deleterious impact on clinical course, strongly associated with progressive heart failure (HF) symptoms. Therefore, we evaluated the impact of AF on QoL utilizing patient reported outcome measures (PROMs).
Background:Catheter ablation (CA) is an effective treatment for atrialfibrillation (AF), but many patients experience recurrence post-intervention. Further research is needed to confirm the clinical relevance of LAS in AF patients undergoing ablation.
METHODS:Retrospective cohort study of patients <21 years of age with HCM/preexcitation from 2000 to 2022. Six (21%) patients had clinical atrialfibrillation (1 with shortest preexcited RR interval <250 ms). Ablation was acutely successful in 13 of 14 patients with recurrence in 3.
24 will focus on the following three current guideline updates: American College of Cardiology (ACC)/American Heart Association (AHA) Guidelines 2023 AtrialFibrillation Guideline - Pharmacology II: Strokes vs. Bleeds, What Do the Guidelines Tell Us About Practical Management in A-fib? The Guidelines Sessions at ACC.24
It is dangerous in WPW with atrialfibrillation. In AtrialFibrillation, the tachycardia will always be irregularly irregular. In Atrial fib with WPW, there will be polymorphic QRS complexes (in this case, all QRS complexes are identical). VT is not harmed by adenosine, When is adenosine dangerous?
Diagnosis : Atrial flutter with 1:1 conduction, with fast AV conduction made possible by sympathetic drive of exercise On arrival, we obtained another 12-lead: Unremarkable Further history: One month history of shortness of breath on exertion, denies palpitations, chest pain, orthopnea, leg swelling. He underwent ablation in the EP Lab.
A patient in the ICU with significant underlying cardiac disease [HFrEF 30%, non-ischemic cardiomyopathy, LBBB s/p CRT-D (biventricular pacer), AVNRT s/p ablation a few yrs ago, hx sinus tachycardia while on max tolerated BB therapy] went into a regular wide-complex tachycardia after intubation for severe COPD exacerbation.
She also has a hx of paroxysmal atrialfibrillation and is on oral anticoagulant treatment. After atrial rhythm/SR was restored the patient slowly improved. Medical treatment for heart failure was optimized and after a few days the patient was discharged with referral to VT ablation procedure.
She was prescribed oral diltiazem to prevent recurrence and was discharged. == MY Comment, by K EN G RAUER, MD ( 10/25 /2022 ): == Today’s blog post reviews the important topic of how to approach the patient who presents with palpitations from an SVT ( S upra V entricular T achycardia ) rhythm. She had an echocardiogram which was normal.
Radiofrequency ablation was performed for a right sided posteroseptal bypass tract. Today's case provides us with an exception to this general rule — in that this previously healthy woman in her 60s presented with a potentially life-threatening arrhythmia ( exceedingly rapid AFib ) that required ablation of her Accessory Pathway.
Rate vs Rhythm Control in AtrialFibrillation Rate vs rhythm control as a management strategy in atrialfibrillation has been a long standing topic for debate. Nearly two thirds in the rhythm control strategy were on amiodarone and only 14 had catheter ablation. Many were not in sinus rhythm or anticoagulated.
Introduction Pulsed-field ablation (PFA) is a novel modality for pulmonary vein isolation in patients with atrialfibrillation (AF). first-time AF ablation. first-time AF ablation. In first-time ablation cases, acute isolation of all pulmonary veins was achieved in 99.5% The patients were 32.1% of patients.
BACKGROUND:Patients undergoing first-time atrialfibrillation (AF) ablation can benefit from targeting non-pulmonary vein (PV) triggers. Preprocedural identification of high-risk individuals can guide planning of ablation strategy. Among all first-time AF ablations, 68.1% were intermediate-risk (score 2, 10.5%
Abstract Introduction The optimized ablation index (AI) value for catheter ablation of atrialfibrillation (AF) remains to be defined. Methods and Results Patients with symptomatic, drug-resistant paroxysmal AF for first ablation were prospectively enrolled from September 2020 to January 2022.
Higher up the cardiovascular patient pathway, AI-based ECG algorithms that create 2D and 3D maps of the heart (Vektor Medical) are being used to shorten ablation procedure times, resulting in reduced procedure costs and patient risks. For example, in March 2023 Bristol Myers Squibb (BMS) partnered with Viz.ai How Has Funding Progressed?
1] Within the complex umbrella of cardiology care and cardiovascular disease, atrialfibrillation ( AFib ) is the most common arrhythmia diagnosed in clinical practice with projections indicating that the prevalence of AFib could reach 15.9 The Increasing Role of Rhythm Control in Patients With AtrialFibrillation.
The American College of Cardiology (ACC) and the American Heart Association (AHA) recently published new guidelines for the diagnosis and management of patients with atrialfibrillation (AF).
Institutional Coronary Artery Bypass Case Volumes and Outcomes European Journal of Heart Failure October 2023 Makoto Mori Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation The Annals of Thoracic Surgery August 2023 Carlos Diaz-Castrillion Volume-Failure to Rescue Relationship in Acute Type A Aortic Dissections: An Analysis of The Society (..)
Institutional Coronary Artery Bypass Case Volumes and Outcomes European Journal of Heart Failure October 2023 Makoto Mori 1 Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation The Annals of Thoracic Surgery August 2023 Carlos Diaz-Castrillion 2 Volume-Failure to Rescue Relationship in Acute Type A Aortic Dissections: An Analysis of The (..)
BackgroundIn medical practice, atrialfibrillation (AF) is intricately associated with heart failure (HF). Currently, ethanol infusion of vein of Marshall (EIVOM) for AF ablation in HF patients remains significantly limited.MethodThis was a non-randomized, single-center, retrospective observational study. vs. 93.9%).
BackgroundIt remains unclear whether the current recommended ablation index (AI) value is suitable for individualized catheter ablation. All the patients underwent AI-guided ablation. UP-EGM was also recorded during the procedure.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content